profit from every $100 of sales.
$0$100
Nano-X Imaging
$0.36-2.52% today
-88.3% in 1 year
1-year low $0.231-year high $4.55
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Nano-X Imaging sold, what it kept, and what it did with the cash.
Sales went from $8.58 million in 2022 to $13.0 million in 2025, with -$75.0 million of profit last year.
SalesProfit
Nano-X Imaging vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Nano-X Imaging | No profit yet | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Nano-X Imaging's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9 | 10 | 11 | 13 | |
| -7 | -7 | -11 | -13 | |
| -87 | -60 | -57 | -61 | |
| -76 | -48 | -45 | -49 | |
| -113 | -61 | -54 | -75 | |
| -2.01 | -1.08 | -0.91 | -1.16 | |
| -80.2% | -66.6% | -94.0% | -98.2% | |
| -1,016.6% | -602.3% | -502.9% | -466.2% | |
| -1,320.2% | -613.6% | -474.3% | -576.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 254 | 219 | 210 | 162 |
| Cash | 38 | 56 | 39 | 49 |
| Total debt | 5 | 8 | 7 | 8 |
| Total liabilities | 37 | 23 | 21 | 22 |
| 217 | 196 | 189 | 140 | |
| 52 | 56 | 59 | 65 | |
| -31.1% | -23.1% | -22.8% | -32.5% | |
| -52.3% | -31.1% | -28.3% | -53.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -43 | -45 | -37 | -41 | |
| 7 | 3 | 3 | 4 | |
| -51 | -48 | -39 | -45 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 19 | 7 | 7 | 4 |
Valuation
- –
- –
- –
- 0.8×
- 2.2×
- –
- –
- -157.0%
- -261.8%
- 0.0%
Profitability
- -98.2%
- -466.2%
- -576.1%
- -376.3%
- -39.7%
- -35.2%
- -47.1%
- -46.3%
- -41.8%
- 147.7%
Growth
- +14.9%
- –
- −14.3%
- –
- +7.7%
Financial health
- -0.8×
- 0.06
- 4.8%
- -407.4×
- 3.96
- 3.77
- 0.08
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 959
Top 37%of 889
What analysts expect
- Average price target
- $18.00
- Range
- $18.00 – $18.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 20, 2026 | -0.50 | -0.23 | −117.4% |
| Nov 20, 2025 | -0.65 | -0.15 | −333.3% |
| Aug 12, 2025 | -0.23 | -0.18 | −31.4% |
| May 22, 2025 | -0.21 | -0.19 | −10.5% |
| Mar 31, 2025 | -0.23 | -0.23 | −1.5% |
| Nov 21, 2024 | -0.23 | -0.22 | −4.5% |
| Aug 20, 2024 | -0.23 | -0.22 | −4.5% |
| Apr 1, 2024 | -0.18 | -0.26 | +30.8% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
42No pass
Benjamin Graham
73Pass
Philip Fisher
30No pass
Peter Lynch
75Pass
Joel Greenblatt
0No pass
Charlie Munger
24No pass
Terry Smith
25No pass
Questions about Nano-X Imaging
Is Nano-X Imaging a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Nano-X Imaging AI analysis
What does Nano-X Imaging do?
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. It is in Medical - Devices.
Does Nano-X Imaging pay a dividend?
No. Nano-X Imaging does not pay a dividend at the moment.
Is Nano-X Imaging stock halal?
No. Nano-X Imaging does not pass our halal screen: its cash and confirmed interest-bearing investments are 172% of its market value, at or above the 33% limit. How we check
How has Nano-X Imaging stock done over the past year?
Down 88.3% over the past twelve months, to $0.36. It traded between $0.23 and $4.55 and is 92.0% below its high.
Who are Nano-X Imaging's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Nano-X Imaging's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.